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ole of yeast. The enzyme was demonstrated to reduce levels 
of guanine in food. A mixture of guanine deaminase and oth-
er purine degradation enzymes will allow the reduction of 
purines in purine-rich foods.  © 2014 S. Karger AG, Basel 
 Introduction 
 Humans absorb different amounts of RNA, DNA, nu-
cleotides, nucleosides and free purine bases from food of 
animal and vegetable origin [Wolfram and Colling, 1987]. 
Purine degradation leads ultimately to CO 2 and ammo-
nia, although in some organisms, intermediate molecules 
accumulate [Hayashi et al., 2000; Keilin, 1959; Lehninger, 
2004]. In humans, purines from exogenous sources (food) 
and purines from cell turnover are both degraded to uric 
acid [Wolfram, 1992; Wolfram and Colling, 1987].
 Reduced renal uric acid excretion combined with in-
creased uric acid synthesis from endogenous and/or ex-
ogenous sources can cause an increase in serum uric acid 
concentration in some individuals [Kutzing and Fireste-
in, 2008; Saag and Choi, 2006; Tausche et al., 2009]. A 
serum concentration >6.8 mg uric acid/dl serum is above 
the physiological saturation level of uric acid and is de-
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 Abstract 
 Purines of exogenous and endogenous sources are degrad-
ed to uric acid in human beings. Concentrations >6.8 mg uric 
acid/dl serum cause hyperuricemia and its symptoms. Phar-
maceuticals and the reduction of the intake of purine-rich 
food are used to control uric acid levels. A novel approach to 
the latter proposition is the enzymatic reduction of the pu-
rine content of food by purine-degrading enzymes. Here we 
describe the production of recombinant guanine deaminase 
by the yeast  Arxula adeninivorans LS3 and its application in 
food. In media supplemented with nitrogen sources hypo-
xanthine or adenine,  guanine deaminase ( AGDA ) gene ex-
pression is induced and intracellular accumulation of gua-
nine deaminase (Agdap) protein occurs. The characteristics 
of the guanine deaminase isolated from wild-type strain LS3 
and a transgenic strain expressing the  AGDA gene under 
control of the strong constitutive  TEF1 promoter were deter-
mined and compared. Both enzymes were dimeric and had 
temperature optima of 55   °   C with high substrate specificity 
for guanine and localisation in both the cytoplasm and vacu-
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fined as hyperuricemia [Terkeltaub, 2010]. A minority of 
patients with hyperuricemia develop microscopic and 
macroscopic monosodium urate crystals, which cause 
swelling, inflammation and/or pain in joints and results 
in painful gout attacks [Sorbera et al., 2010; Terkeltaub, 
2010]. Between 1 and 2% of the population in industrial 
countries are affected by this disease [Burns and Wort-
mann, 2011; Eggebeen, 2007; Sorbera et al., 2010].
 Patients with acute gout attacks are treated with 
NSAIDs (non-steroidal anti-inflammatory drugs), col-
chicine or in rare cases, with corticosteroids or interleukin-
1β inhibitors [Groff et al., 1990; Jordan, 2012; Tausche et 
al., 2009; Terkeltaub et al., 2010]. In symptomless inter-
vals between attacks, uricostatic agents (allopurinol or fe-
buxostat) which reduce uric acid synthesis by inhibition 
of xanthine oxidoreductase [Eggebeen, 2007; Hu and 
Tomlinson, 2008; Pascual et al., 2009; Wittköpper et al., 
2011], uricosuric agents (probenecid or benzbromarone) 
which promote uric acid excretion [Eggebeen, 2007; Em-
merson, 1996] or recombinant urate oxidase (rasburicase 
or pegloticase) which enzymatically degrade uric acid 
[Leinmüller, 2001; Schlesinger et al., 2011; Sharma and 
Verma, 2004; Sundy et al., 2007] are used.
 The uptake of exogenous purines can be reduced by 
decreasing the intake of purine-rich food such as meat 
(especially muscle tissue, bowel and skin), fish (herring 
and shrimps) and some plants (soy and other legumes) 
[Wolfram, 1992; Wolfram and Colling, 1987]. Addition-
ally, avoidance of alcohol and loss of weight are useful in 
the prevention of gout attacks [Wolfram, 1992].
 Our approach to prevent hyperuricemia involves the 
addition of a mixture of different purine-degrading en-
zymes to the food, either during production or during 
ingestion. This study characterises one of those enzymes, 
guanine deaminase, and investigates its performance in a 
purine-rich food.
 Guanine deaminase (EC 3.5.4.3, guanine aminohy-
drolase), is a metal-dependent enzyme that is highly con-
served, and was first described in 1932 [Schmidt, 1932]. 
It catalyses the irreversible deamination of guanine to 
xanthine and ammonia [Fernández et al., 2010; Glantz 
and Lewis, 1978; Lehninger, 2004; Maynes et al., 2000]. It 
is responsible for purine degradation in bacteria [Liaw et 
al., 2004; Maynes et al., 2000], lower eukaryotes [Nolan, 
1984; Saint-Marc and Daignan-Fornier, 2004; Shavlov-
skii and Kuznetsova, 1974], plants [Barankiewicz and 
Paszkowski, 1980; Negishi et al., 1994] and is present in 
the liver [Gupta and Glantz, 1985; Lewis and Glantz, 
1974] and kidney [Kubo et al., 2006] of higher eukaryotes. 
Guanine deaminase was also found to be active in the 
brain of higher eukaryotes [Berger et al., 1985; Kumar and 
Rathi, 1980; Miyamoto et al., 1982; Rossi et al., 1978] 
where it plays an important role in the branching of den-
drites [Fernández et al., 2009].
 In this study the  guanine deaminase  ( AGDA ) gene was 
isolated from the non-conventional, arthroconidial, xe-
rotolerant, anamorphic, non-pathogenic yeast,  Arxula 
adeninivorans LS3 [van der Walt et al., 1990]. The yeast 
is able to assimilate and use a broad range of substrates, 
including purines,  n -alkanes and starch as sole energy 
and carbon sources and nitrate as a sole nitrogen source 
[Böer et al., 2009c; Gienow et al., 1990; Middelhoven et 
al., 1984]. It can be cultured at up to 48  °  C and 20% NaCl 
[Wartmann et al., 1995; Yang et al., 2000]. Above 42   °   C 
the morphology changes from budding cells to mycelia 
[Wartmann et al., 1995].
 The  ADGA  gene was overexpressed to produce high 
concentrations of recombinant guanine deaminase pro-
tein. Additionally, the application of the enzyme in a pro-
cess to reduce purines in food was investigated.
 Results 
 Identification and Characterisation of the AGDA 
Gene 
 The putative nucleotide sequence of the  AGDA gene 
was determined from the complete  A. adeninivorans se-
quence and annotated genome [manuscript in progress] 
and the  AGDA gene was located as single copy on chro-
mosome 4. The ORF of the  AGDA gene comprises 1,428 
bp which encodes a protein with 475 amino acids (mo-
lecular mass 53 kDa; isoelectric point 5.7). Agdap has 
identity with other fungal guanine deaminases, including 
 Ogataea parapolymorpha DL-1 (accession: EFW97840 – 
55%),  Komagataella pastoris GS115 (XP_002490656 – 
51%),  Saccharomyces cerevisiae strains (CAY79050, 
EDN60126 and EEU08967 – 49–50%),  Ajellomyces der-
matitidis strains (EEQ86158 and XP_002620893 – 45%), 
 Schizosaccharomyces pombe 972h- (NP_587874 – 48%) 
and  Paracoccidioides brasiliensis Pb03 (EEH21407 – 
44%).
 Nitrogen Source-Dependent Expression of the AGDA 
Gene 
 The analysis of  AGDA transcription regulation was 
done with qRT-PCR and the  Arxula genes  AHBS4 ,  ALG9 , 
 TEF1 and  TFIID as stably expressed endogenous refer-
ences. The wild-type strain was cultured in YMM-glucose 
supplemented with 43.5 m M NH 4 H 2 PO 4 as nitrogen 
 Arxula adeninivorans Guanine Deaminase 
and Its Application 
 J Mol Microbiol Biotechnol 2014;24:67–81
DOI: 10.1159/000357674
69
source (N-source) for 24 h at 30  °  C before the washed cells 
were shifted to YMM-glucose containing 5 m M adenine, 
5 m M hypoxanthine or 5 m M NaNO 3 as nitrogen source. 
The normalised relative quantity of  AGDA transcript was 
calculated as ratio of the transcript in a sample (YMM-
glucose-purine) to the transcript in the control (YMM-
glucose-NaNO 3 ). Immediately after the shift of cells into 
media with purine as nitrogen source, the  AGDA tran-
script level increased and reached maximum level at 2 h 
with adenine and 4 h with hypoxanthine, after which 
transcription fell to the basal level. The maximal tran-
script level was 2-fold higher in cells cultured in YMM-
glucose-hypoxanthine than in cells cultured in YMM-
glucose-adenine ( fig. 1 a).
 The crude extract of  A. adeninivorans LS3 yeast cells, 
cultured under the same conditions, was used for the de-
termination of Agdap activity. After a shift from YMM-
glucose-NH 4 H 2 PO 4 to YMM-glucose supplemented with 
5 m M adenine, 5 m M hypoxanthine or 0.2 m M guanine as 
a nitrogen source, the enzymatic activity strongly in-
creased which is in contrast to uric acid as nitrogen source 
where the activity increase was minimal ( fig.  1 b). The 
negative controls (YMM-glucose-NH 4 H 2 PO 4 or YMM-
glucose-NaNO 3 ) showed no increase of Agdap activity. 
The maximal Agdap activity was achieved 6 h after the 
shift to adenine or hypoxanthine.
 The effect of various concentrations of inducer on 
 AGDA transcript level was determined by harvesting cells 
2 h after a shift to YMM-glucose containing different con-
centrations (0.5, 1, 3, 4, 5 m M ) of hypoxanthine, uric acid, 
adenine and NaNO 3 as nitrogen sources and analysing 
for the  AGDA transcript. Low inducer concentrations 
(0.5 and 1 m M ) resulted in low  AGDA transcript levels 
whereas concentrations of 3 m M or higher increased the 
mRNA accumulation ( fig. 1 c) with the highest level being 
achieved with 3 m M hypoxanthine.
 Because the low activity at 2 h, guanine deaminase ac-
tivity was analysed 4 h after the shift to YMM-glucose-
nitrogen sources ( fig.  1 d). At 4 h, Agdap activity had 
strongly increased with concentrations of 1 m M or great-
er of hypoxanthine 0.24–0.30 U/mg protein, adenine 
0.15–0.22 U/mg protein and 0.2 m M guanine 0.11 U/mg 
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Fig. 1. Influence of the nitrogen source on 
 AGDA transcript accumulation ( a ,  c ) and 
Agdap activity ( b ,  d ). Normalised relative 
quantity of  AGDA transcript level was ana-
lysed with qRT-PCR and calculated ac-
cording to Hellemans et al. [2007] with 
 Arxula genes  AHBS4 ,  ALG9 ,  TEF1 and 
 TFIID used as stably expressed endogenous 
references.  A. adeninivorans LS3 was cul-
tured 24 h at 30    °    C in YMM-glucose-
NH 4 H 2 PO 4 (43.5 m M ) before being shifted 
to YMM-glucose supplemented with dif-
ferent nitrogen sources ( a ) 5 m M adenine, 
hypoxanthine or NaNO 3 for 24 h, ( b ) 5 m M 
adenine, hypoxanthine, uric acid, NaNO 3 , 
NH 4 H 2 PO 4 or 0.2 m M guanine for 48 h, ( c ) 
0.5, 1, 3, 4 and 5 m M adenine, hypoxanthine 
or NaNO 3 for 2 h, and ( d ) 0.25, 0.5, 1, 2.5 
and 5 m M adenine, hypoxanthine, uric 
acid, NH 4 H 2 PO 4 or 0.2 m M guanine for 4 h.
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protein. Uric acid as a nitrogen source again induced low 
Agdap activity (<0.07 U/mg protein). YMM-glucose-
NH 4 H 2 PO 4 showed only weak guanine deaminase activ-
ity which was independent of NH 4 H 2 PO 4 concentration.
 Production of Recombinant Guanine Deaminase, 
Agdap 
 The  AGDA gene was overexpressed under the control 
of the strong constitutive  TEF1 promoter in the auxotro-
phic  A. adeninivorans G1212 strain (Δ atrp1 ) using the 
Xplor ® 2 transformation/expression platform [Böer et al., 
2009b]. Xplor ® 2 allows the construction of resistance 
marker-free yeast vectors with selection and expression 
modules as described in the Materials and Methods sec-
tion. The vector for control contains only the selection 
module. The linear vector fragments were introduced 
into the  A. adeninivorans G1212 strain as yeast rDNA in-
tegrative expression cassettes (YRC, digested with  Asc I) 
and yeast integrative expression cassettes (YIC, digested 
with  Sbf I) ( fig. 2 ).
 For initial screening the protein extracts from approx-
imately 50 transformants per construct (cultured 24 h in 
YMM-glucose-NaNO 3 ) were analysed for recombinant 
Agdap or Agda6hp activity (data not shown). Increased 
guanine deaminase activity was observed in most trans-
formants in comparison to the controls G1212/YIC102 
and G1212/YRC102.
 The transgenic strains with highest Agdap activity 
were analysed in time course experiments over 96 h at 
30   °   C in YMM-glucose-NaNO 3 . The cultivation condi-
tions resulted in stationary growth phase being reached 
after approximately 24 h with all strains ( fig. 3 ) exhibit-
ing an increased level of intracellular Agdap or Agda6hp 
after 24 h (52–73 U/g dry cell weight (dcw); 320–430 U/l 
culture) before decreasing to basal level. The control 
strains, without expression modules, gave Agdap activi-
ties <5 U/g dcw, although there was no difference detect-
able in the biomass of transgenic strains and controls. 
The activity levels of YRC and YIC were also comparable. 
The highest activity was achieved with G1212/YRC102-
TEF1-AGDA6H.
 Purification and Molecular Mass Estimation 
 The endogenous guanine deaminase from  A. adenini-
vorans LS3 was purified to homogeneity from induced 
cells cultured for 24 h in YMM-glucose-NaNO 3 before 
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 Fig. 2. Physical maps of yeast transformation/expression cassettes 
(YRC and YIC) used in this study. The selection module contains 
the selection marker  ATRP1m fused to the  ALEU2 promoter. The 
selection module is fused to none ( a ) or one ( b ,  c ) expression mod-
ule. The expression modules contain the following elements: 
 A.  adeninivorans -derived  constitutive  TEF1 promoter,  AGDA -
coding sequence and  S. cerevisiae -derived  PHO5 terminator. 
 AGDA -coding sequence is fused to C-terminal HisTag ( c ) encod-
ing sequence. YRCs are flanked by 25S rDNA sequences for target-
ing; YICs are without 25S rDNA targeting sequences. 
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being shifted to YMM-glucose-hypoxanthine (5 m M ) for 
6 h as described in the Materials and Methods section. 
The specific activity in these cells was 4.7 U/mg of protein 
( table  1 ). After the purification steps, a single protein 
band with an approximate molecular mass of 55 kDa was 
detected ( fig. 4 a) on denaturing SDS-PA gel and given by 
MALDI-TOF mass spectrometry. The protein in the 
band was digested with the endopeptidase trypsin into 
peptides, which revealed an amino acid overlay of 63% 
with the putative Agdap amino acid sequence from 
 A.  adeninivorans LS3 ( fig. 4 b).
 The recombinant Agda6hp was purified by column 
chromatography on His-Bind resin as described in the 
Materials and Methods section, separated with denatur-
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 Fig. 3. Expression of guanine deaminase over time by transgenic 
 A. adeninivorans strains. Transformants G1212/YIC102-TEF1-
AGDA ( a ), G1212/YIC102-TEF1-AGDA6H ( b ), G1212/YIC102 
( c ), G1212/YRC102-TEF1-AGDA ( d ), G1212/YRC102-TEF1-
AGDA6H ( e ) and G1212/YRC102 ( f ) were cultured in shake flasks 
for 96 h at 30   °   C in the presence of YMM-glucose-NaNO 3 . At the 
indicated time, 2-ml aliquots of the culture were assayed for intra-
cellular guanine deaminase activity (U/l culture) to determine bio-
mass (g/l culture) and to calculate the guanine deaminase output 
(U/g dcw) as described in the Materials and Methods section. 
Table 1.  Purification steps for endogenous guanine deaminase synthesized by wild-type  A. adeninivorans LS3
Step Total protein,
mg
Total activity,
U
Specific activity,
U/mg
Yield,
%
Purification,
fold
Crude extract 223.2 20.2 0.1 100 1
Heat precipitation 18.8 14.5 0.8 71.5 8.5
DEAE-Sepharose column 2.6 5.0 1.9 24.7 21.2
SuperdexTM 200 column 0.3 1.2 4.7 6.0 51.5
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ing SDS-PAGE ( fig. 4 c), treated with anti-HisTag-specific 
antibodies ( fig. 4 d) and detected at approximately 55 kDa.
 The molecular mass of endogenous and recombinant 
guanine deaminase proteins were determined by gel fil-
tration on Superdex TM 200 column with both enzymes 
having a molecular mass between 100 and 110 kDa 
 ( table 2 ). The active enzymes are probably homodimers.
 Enzymatic Analysis and Subcellular Localisation of 
Agdap and Agda6hp 
 The temperature optimum was similar for endoge-
nous and recombinant guanine deaminase (55  °  C) but the 
thermostability after incubation for 1 h was higher for 
endogenous Agdap (60   °    C) than for the recombinant 
 Agda6hp (30   °   C) ( table  2 ). The Agdap from wild-type 
strain has optimal pH values of 6.5 and 8.0 whereas the 
recombinant Agda6hp showed a single optimum of pH 
6.5. Both enzymes are stable during incubation for 1 h at 
37  °  C with pH in the range of 6.5–8.0. The Michaelis con-
stant for both enzymes was determined by Hanes-Woolf 
plot and calculated to be approximately 56 μ M for endog-
enous guanine deaminase and 26 μ M for recombinant 
guanine deaminase.
 The enzymatic activity of guanine deaminase was re-
duced by storage at 22 and 4   °   C ( table 3 ) to be less than 
50% after 28 days, while at the activity increased up to 
123% with storage at –20  °  C. The addition of the protect-
ing agent glycerine also had negative effects on the resid-
ual activity.
 The intracellular localisation of endogenous (data not 
shown) and recombinant ( fig. 5 ) guanine deaminases was 
analysed by sucrose density gradient centrifugation as de-
scribed in the Materials and Methods section. The highest 
enzymatic activity was detected in fractions 17 and 18 for 
both enzymes; in flanking fractions the activity decreased 
by up to 70%. The vacuole marker enzyme, α-mannosidase, 
exhibited activities of more than 80% in fractions 16–18 
and decreasing to 50% in flanking fractions. The enzymat-
ic activity of cytosolic marker enzyme, glucose-6-phos-
phate dehydrogenase, was detectable in fractions 19–22.
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 Fig. 4. Analysis of purification of guanine deaminase.  a ,  b  A. ade-
ninivorans LS3 cells were cultured for 24 h at 30   °   C in YMM-glu-
cose-NaNO 3 before being shifted to YMM-glucose-hypoxanthine 
(5 m M ) for 6 h. After harvesting and disrupting of cells, the crude 
extract (extract) was purified by heat precipitation (heat), DEAE 
ion exchange chromatography (DEAE), Superdex TM 200 chroma-
tography (Superdex) and electrophoresed by SDS-PAGE (12%). 
The marked protein band (arrow) was analysed with MALDI-TOF 
mass spectrometry (detected peptides are accented in bold type). 
 c ,  d  A. adeninivorans G1212/YRC102-TEF1-AGDA6H cells were 
cultured for 24 h in 30   °   C in YMM-glucose-NaNO 3 , harvested, 
crude extracts prepared (extract) and purified by Ni-NTA chro-
matography. Following purification steps, extract with binding 
buffer (extract + BB), flow-through 1st (flow1), flow-through 2nd 
(flow2), washing with 5 m M imidazole (wash1), washing with 20 
m M imidazole (wash2), eluate 1 (e1), eluate 2 (e2), eluate 3 (e3), 
eluate 4 (e4), eluate 5 (e5) (all eluation steps with 1 ml 1  M imidaz-
ole) and mixture of eluate 1 and 2 (e mix), were ( c ) electrophoresed 
on 12% SDS-PA gel and ( d ) analysed by immunoblot analysis with 
anti-HisTag antibodies. 
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 The influence of metal ions and other reagents on en-
dogenous Agdap and recombinant Agda6hp ( table 4 ) was 
assessed and the resulting activity compared with a con-
trol without added metal ions (100% activity). The pres-
ence of Cu 2+ or Hg 2+ reduced the enzymatic activity of 
both enzymes by more than 75%. The addition of 1 m M 
Ni 2+ caused a reduction in the activity for both enzymes 
whereas the addition of 1 m M DTT or  L -cysteine reduced 
the activity of the recombinant guanine deaminase only. 
The other metals and reagents ( table 4 ) had no effect or 
only weak effects at the tested concentrations.
 Both guanine deaminases were analysed for substrate 
specificity. The highest activity of Agdap and Agda6hp 
was obtained with guanine (100%) while activity with 
6-thioguanine and 8-azaguanine was less than 10% (data 
not shown). There was no activity with other purine de-
rivatives such as adenine, adenosine and guanosine. The 
addition of guanosine to an enzymatic reaction with gua-
nine as the substrate caused a decrease of enzymatic activ-
ity by approximately 50% ( table 5 ). All the other purine 
derivatives that were trialled had no effect or only weak 
effects on the activity of endogenous Agdap and recom-
binant Agda6hp.
 Use of Guanine Deaminase in a Mixture of Enzymes 
to Reduce Purines in Food 
 Beef stock (50 mg/ml REWE Bio Rinderbrühe; REWE, 
Germany), containing 35.2 mg/l guanine, 0.2 mg/l uric 
acid, 1.8 mg/l xanthine, 3.4 mg/l adenine and 13.4 mg/l 
hypoxanthine [Trautwein-Schult et al., 2013], was anal-
Table 2.  Properties of the endogenous (Agdap) and recombinant 
guanine deaminase (Agda6hp) synthesized in  A.  adeninivorans 
LS3 and G1212/YRC102-TEF1-AGDA6H
Property Agdap Agda6hp
pH optimum 6.5 and 8.0 6.5
pH stability 6.5–8.0 6.5–8.0
Temperature optimum 55°C 55°C
Temperature stability up to 60°C up to 30°C
Michaelis constant, Km 56 μM 26 μM
kcat 3.9 1/s 1.5 1/s
Mr native 100–110 kDa 100–110 kDa
Mr denatured 55 kDa 55 kDa
 The Michaelis constant was estimated using a Hanes-Woolf 
plot. pH stability was defined as the range of activity and thermal 
stability as highest temperature by which 80% of the initial activity 
was retained after an incubation time of at least 60 min. The prop-
erties were determined in at least three independent experiments 
with maximal aberration of 10% with standard assay for ammonia 
quantification.
Table 3.  Stability of guanine deaminase of  A. adeninivorans LS3 
under different storage conditions
Storage condition 0 days,
%
1 day,
%
7 days,
%
14 days,
%
28 days,
%
22°C 100 86 79 72 34
4°C 100 93 77 72 44
–20°C 100 100 103 117 123
–20°C with 20% glycerine 100 45 39 64 65
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 Fig. 5. Subcellular localisation of recombi-
nant guanine deaminase Agda6hp.  A. ade-
ninivorans G1212/YRC102-TEF1- AGDA6H 
protoplasts were disrupted and loaded onto a 
sucrose density gradient as described in the 
Materials and Methods section. Each fraction 
was analysed for the refractive index of su-
crose and enzymatic activity of guanine de-
aminase, the vacuole marker enzyme, 
α-mannosidase, and cytoplasmic marker en-
zyme, glucose-6-phosphate dehydrogenase. 
 Trautwein-Schult   et al.  J Mol Microbiol Biotechnol 2014;24:67–81
DOI: 10.1159/000357674
74
ysed as described in the Materials and Methods ( fig. 6 a). 
The purine content of this product was reduced by incu-
bation with an enzyme mixture containing 0.2 U/ml gua-
nine deaminase, 0.2 U/ml urate oxidase, 0.2 U/ml adenine 
deaminase and 0.2 U/ml xanthine oxidoreductase. After 
incubation for 240 min at 40  °  C, the purine content was 
reduced to 3.3 mg/l guanine, 0 mg/l uric acid, 0.1 mg/l 
xanthine, 0 mg/l adenine and 2.5 mg/l hypoxanthine 
( fig. 6 b).
 The results of analysis of rolled fillet of ham are 
shown in  table 6 . The untreated food contained 21.13 
mg/l guanine and smaller amounts of hypoxanthine 
(9.41 mg/l), adenine (1.38 mg/l), xanthine (1.08 mg/l) 
(No. 1). Uric acid was not detected. The incubation of 
dissolved rolled fillet of ham over 120 min or 240 min 
with the enzyme mixture (0.05 U/ml guanine deami-
nase, 0.05 U/ml urate oxidase, 0.05 U/ml adenine de-
aminase and 0.05 U/ml xanthine oxidoreductase) caused 
a reduction of the each purine in this kind of food (Nos. 
3 and 4). The addition of more purine-degrading en-
zymes (each 0.2 U/ml) led to a faster decrease of the 
purine content (Nos. 6 and 7).
 Discussion 
 Between 1 and 2% of the population in industrial 
countries suffers from gout, a painful result of hyperuri-
cemia [Burns and Wortmann, 2011; Eggebeen, 2007; 
Sorbera et al., 2010]. In symptomless intervals between 
gout attacks, uricostatic or uricosuric agents and in some 
cases recombinant urate oxidase are given to reduce the 
uric acid content of serum [Eggebeen, 2007; Jordan, 2012; 
Leinmüller, 2001; Schlesinger et al., 2011; Tausche et al., 
2009; Terkeltaub, 2010; Wittköpper et al., 2011]. Further-
more, avoidance of purine-rich food, reduction of alcohol 
intake and reduction of weight are helpful [Wolfram, 
1992; Wolfram and Colling, 1987]. This study contributes 
further evidence that enzymatic reduction of the purine 
content of food during production or ingestion by treat-
ment with a mixture of purine-degrading enzymes will 
also be a useful contributor to the reduction of hyperuri-
cemia and its associated symptoms such as gout.
 Genome data of  A. adeninivorans LS3 and sequence 
data of known  AGDA genes were used to identify the 
 AGDA gene. The amino acid sequence of the 1,428-bp 
ORF showed higher identity (44–55%) to other fungal 
guanine deaminases than it did to either  Escherichia coli 
deaminase or human deaminase (36% identity) [Maynes 
et al., 2000]. The sequence PGFFDTHIH (position 90–
Table 4.  Effects of various metal ions and other compounds on the 
stability and activity of the endogenous and recombinant guanine 
deaminase (Agdap and Agda6hp) synthesised in  A. adeninivorans 
LS3 and G1212/YRC102-TEF1-AGDA6H respectively
Compound Concentration, 
mM
Agdap
activity, %
Agda6hp
activity, %
Control, without
compound – 100 100
CaCl2 1/0.1 103/100 100/102
CuCl2 1/0.1 22/20 1/1
CuSO4 1/0.1 22/23 1/2
FeCl3 1/0.1 101/102 102/101
KCl 1/0.1 102/100 100/95
MgCl2 1/0.1 97/103 113/109
NiCl2 1/0.1 90/86 90/84
NiSO4 1/0.1 90/85 90/78
ZnCl 1/0.1 103/94 100/92
ZnSO4 1/0.1 98/91 97/88
EDTA 1/0.1 101/102 96/94
HgCl2 1/0.1 0/1 0/1
1,10-Phenanthroline 1/0.1 97/98 104/106
DTT 1/0.1 104/103 100/80
L-Cysteine 1/0.1 108/111 98/73
PMSF 1/0.1 111/112 100/102
 The enzyme was incubated for 1 h at 37°C in PP-buffer pH 6.0 
containing the listed concentrations of supplements. The residual 
activity was measured in at least three independent experiments 
with a standard enzyme assay (ammonia quantification) as de-
scribed in the Materials and Methods section.
Table 5.  Effects of purine derivatives on endogenous (Agdap) and 
recombinant guanine deaminase (Agda6hp) activity
Purine Agdap
activity, %
Agda6hp
activity, %
Control (without additional purine) 100 100
Adenine 102 85
Adenosine 98 91
2-Amino-6-chloropurine 93 88
8-Azaguanine 99 95
8-Azaxanthine 95 88
2,6-Diaminopurine 107 98
Guanosine 48 70
Hypoxanthine 100 87
Uric acid 89 86
Xanthine 91 87
 The enzyme reaction was performed under standard condi-
tions (ammonia quantification), except that the purine derivatives 
were added at the same concentration as guanine (1.3 mM) to the 
reaction buffer. The residual activity was measured as described in 
the Materials and Methods section.
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98) was homologous to the conserved sequence PGX[V/I]
DXH[T/V/I]H (X: each amino acid) in eukaryotic and 
archaeal guanine deaminases described by Fernández et 
al. [2009]. This sequence is common in the amidohydro-
lases family [Kim and Kim, 1998] and has been described 
in guanine deaminases of  E. coli ,  S. cerevisiae and hu-
mans [Maynes et al., 2000; Saint-Marc and Daignan-
Fornier, 2004; Snyder et al., 2000]. The amino acid se-
quence of  A. adeninivorans LS3 did not, however, con-
tain signal sequences for intracellular localisation or for 
secretion.
 In  A. adeninivorans LS3, the  AGDA gene is up-regu-
lated by adenine and hypoxanthine (maximum at 2 and 
4 h respectively) although the increase of enzymatic activ-
ity was delayed in media with guanine, adenine and hy-
poxanthine as nitrogen sources to be at a maximum at 
6 h. This effect can be explained by the higher stability of 
Agdap compared to the  AGDA transcript, which is neces-
sary to protect the cell from intracellular accumulation of 
purines. This is consistent with Roush et al. [1959] who 
observed an increase in enzymatic guanine deaminase ac-
tivity of  Candida utilis in the presence of purines. In an-
other investigation, the promoter of  guanine deaminase 
from  B. subtilis was fused to a reporter gene [Nygaard et 
al., 2000]. Under nitrogen-limiting conditions the activ-
ity of the reporter gene was 10-fold higher than it is in 
nitrogen-rich conditions [Nygaard et al., 2000]. Addi-
tionally, an increase in the presence of adenine, hypoxan-
thine or guanosine as nitrogen sources was described by 
Nygaard et al. [2000].
 The induction of mRNA transcription by purines and 
the nitrogen source-dependent guanine deaminase activ-
ity did not allow accumulation of the protein in wild-type 
 A. adeninivorans LS3. This problem was mitigated in the 
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 Fig. 6. HPLC analysis of beef stock incu-
bated with purine-degrading enzymes. The 
profile of the beef stock solution with en-
zyme mix containing 0.2 U/ml guanine de-
aminase, 0.2 U/ml urate oxidase, 0.2 U/ml 
adenine deaminase and 0.2 U/ml xanthine 
oxidoreductase in the presence of 3 mg/ml 
NAD + ( a ) without incubation and ( b ) after 
240 min at 40   °   C. Purine standards were 
used for determination of the retention 
time of adenine (ade), hypoxanthine (hx), 
xanthine (x), guanine (gua, two peaks) and 
uric acid (ua). 
Table 6.  HPLC analysis of macerated rolled fillet of ham incubated with purine-degrading enzymes. The samples were treated with dif-
ferent amounts of enzyme mixture and for different incubation times
Sample
No.
Enzyme mix,
U/ml
Incubation
time, min
 Purine amount, mg/l
adenine hypox anthine xanthine guanine uric acid
1 0 0 1.38 9.41 1.08 21.13 0
2 0.05 0 0.77 7.35 2.90 22.07 0
3 0.05 120 0.30 0 0 0.44 0
4 0.05 240 0 0 0 0 0
5 0.2 0 0.34 6.57 3.46 17.47 0
6 0.2 120 0 0 0.32 0 0
7 0.2 240 0 0 0 0 0
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recombinant strains by using the strong constitutive 
 TEF1 promoter with the Xplor ® 2 platform as previously 
described for other biotechnologically interesting en-
zymes such as Alip1p [Böer et al., 2005], Atan1p [Böer et 
al., 2009a] or RR-ADH [Giersberg et al., 2012].
 In this study, transgenic strains were assessed for ac-
cumulation of recombinant Agdap or Agda6hp (HisTag). 
The highest activity was achieved by G1212/YRC102-
TEF1-AGDA6H at the end of stationary growth phase 
(24 h). It is possible that production of the recombinant 
enzyme for biotechnological applications may be in-
creased by cultivation in fed-batch fermentation mode as 
observed for tannase production by  A. adeninivorans 
[Böer et al., 2011].
 The differences between YIC and YRC transgenic 
strains were small as previously described for recombi-
nant alcohol dehydrogenase from  Rhodococcus ruber 
produced in different yeast species [Giersberg et al., 
2012]. In contrast, the maximal expression level of re-
combinant phytase K and human interferon α was 
achieved in YIC strains [Böer et al., 2009b]. The number 
of integrations was investigated with Southern blot analy-
ses (data not shown) which showed that one transgenic 
strain had two integrations of the expression cassette 
(G1212/YRC102-TEF1-AGDA) whereas all the other 
transgenic strains contained a single integration. The 
number of integrations did not have an effect on maximal 
enzymatic activity of recombinant guanine deaminase, 
although Steinborn et al. [2007a] observed a higher ex-
pression level with increased number of integrations of 
α-amylase in  A. adeninivorans . The stability of both re-
combinant guanine deaminases (Agdap and Agda6hp) 
was the same, which is in contrast to recombinant urate 
oxidase with a C-terminal HisTag, which increased sta-
bility of enzymatic activity when compared with urate 
oxidase without the C-terminal HisTag or with N-termi-
nal HisTag [Trautwein-Schult et al., 2013].
 Guanine deaminase comprises two subunits each with 
a molecular mass of 55 kDa. The enzyme produced by 
other organisms may be monomeric or dimeric [Glantz 
and Lewis, 1978; Maynes et al., 2000; Negishi et al., 1994; 
Nolan, 1984]. Guanine deaminases have been reported to 
have molecular masses per subunit of between 50 and 
60 kDa [Bergstrom and Bieber, 1979; Gupta and Glantz, 
1985; Miyamoto et al., 1982; Rossi et al., 1978], which is 
consistent with our findings.
 The endogenous Agdap from  A. adeninivorans LS3 has 
two pH optima, which is also the case for the guanine de-
aminase of  Camellia sinensis  [Negishi et al., 1994]. This is 
in contrast to guanine deaminases of other organisms, 
which have a single optimum between pH 6.8 and 9.4 
[Bergstrom and Bieber, 1979; Fogle and Bieber, 1975; Mi-
yamoto et al., 1982; Nolan, 1984]. The temperature opti-
mum of the wild-type  Arxula enzyme is relatively high at 
55  °  C and the stability of enzymatic activity over an incu-
bation of 1 h at 60  °  C is the highest ever recorded for a gua-
nine deaminase [Glantz and Lewis, 1978; Gupta and 
Glantz, 1985; Nolan, 1984]. However, in contrast, the re-
combinant  Arxula  Agda6hp did not exhibit that level of 
thermostability. The reason for this and other changes in 
properties could be the C-terminal HisTag, which can in-
fluence protein structure and charge [Votchitseva et al., 
2006]. The K m values are similar to the values described 
for other guanine deaminases (4–42 μ M ) [Bergstrom and 
Bieber, 1979; Fogle and Bieber, 1975; Maynes et al., 2000; 
Miyamoto et al., 1982; Negishi et al., 1994; Nolan, 1984; 
Rossi et al., 1978].
 The determination of subcellular localisation of gua-
nine deaminase using sucrose density gradient centrifu-
gation suggested a dual localisation in the vacuole and 
in the cytoplasm. In contrast, histochemical and immu-
nohistochemical analyses of human kidney and liver as-
signed cytoplasmic localisation [Ito et al., 1989; Kubo et 
al., 2006], which was also shown by differential centrif-
ugation in rat and mouse brain cells [Kumar et al., 
1972].
 The addition of ions such as calcium, magnesium or 
iron, which are constituents of many foods, showed no 
effect on the enzymatic activity of the guanine deami-
nase. However, toxic ions such as copper and mercury 
decreased the guanine deaminase activity of both the en-
dogenous and recombinant proteins. Guanine deami-
nase from other organisms also showed the same inhibi-
tion with the addition of Cu 2+ [Negishi et al., 1994] and 
organic mercury compounds such as  p -chloromer-
curibenzoic acid and  p -hydroxymercuribenzoic acid 
[Bergstrom and Bieber, 1979; Glantz and Lewis, 1978; 
Gupta and Glantz, 1985; Negishi et al., 1994]. These re-
sults suggest that sulfhydryl groups may be located near 
the active site of the enzyme. EDTA also inactivated gua-
nine deaminase from the rat brain and  C. sinensis [Miya-
moto et al., 1982; Negishi et al., 1994]. It was shown that 
the loss of zinc atoms in  E. coli leads to inactivation of the 
enzyme [Maynes et al., 2000]. While the guanine deami-
nase from  A. adeninivorans contains the conserved zinc-
binding domain (data not shown), the existence of zinc 
or another metal in the catalytic site of the enzyme was 
not proven.
 The substrate spectra of guanine deaminase from 
 A. adeninivorans is the same as those previously described 
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for guanine deaminases of human and rat liver and other 
organisms [Bergstrom and Bieber, 1979; Glantz and Lew-
is, 1978; Gupta and Glantz, 1985; Miyamoto et al., 1982; 
Rossi et al., 1978]. However, the inhibitory effect of gua-
nosine was less than that observed by Kim et al. [2009]. 
Food contains different amounts of RNA, DNA, nucleo-
tides and nucleosides [Wolfram and Colling, 1987] and 
the reduction of the negative effect of guanosine on the 
recombinant enzyme should be advantageous in its ap-
plication for food treatment.
 We have also demonstrated that the inclusion of 
 Agda6hp in an enzyme mixture containing guanine de-
aminase, urate oxidase [Trautwein-Schult et al., 2013], 
xanthine oxidoreductase [Jankowska et al., 2013b] and 
adenine deaminase [Jankowska et al., 2013a] reduces the 
content of purines in different kinds of food. The product 
of a single reaction serves as substrate for another enzyme 
and the final product is allantoin, which is 5–10 times 
more soluble than uric acid. To complete our uric acid 
reduction system, purine nucleoside phosphatase [in 
progress] and non-specific phosphatases such as Apho1p 
[Kaur et al., 2007], an  Arxula phosphatase of broad sub-
strate specificity, will need to be added to the enzyme 
mixture to ensure the reduction purines and its deriva-
tives in food. This approach will lead to a new application 
to prevent hyperuricemia.
 Materials and Methods 
 Strains, Media and Cultivation 
 E. coli XL1-Blue ( recA1 endA1 gyrA96 thi-1 hsdR17 supE44 
relA1 lac  [ F ′ proAB lacI q Z Δ M15  Tn 10 (Tet r )]), obtained from 
Stratagene (La Jolla, Calif., USA), served as the host strain for bac-
terial transformation and plasmid isolation. It was grown on LB 
medium supplemented with ampicillin (100 μg/ml; AppliChem 
GmbH, Darmstadt, Germany) or kanamycin (50 μg/ml; Carl Roth 
GmbH, Karlsruhe, Germany) for selection.
 The wild-type yeast strain,  A. adeninivorans LS3, isolated in 
Siberia (Russia) from wood hydrolysates [Gienow et al., 1990] and 
deposited as  A. adeninivorans SBUG 724 in the strain collection of 
the Department of Biology of the University of Greifswald, and the 
auxotrophic mutant  A. adeninivorans G1212 [ aleu2 atrp1::ALEU2 ] 
[Steinborn et al., 2007b], were used in this study.
 Yeast strains were cultured at 30  °  C under non-selective condi-
tions in yeast extract-peptone medium (YEPD) or under selective 
conditions in a yeast minimal medium supplemented with 1% 
(w/v) glucose (YMM-glucose) as carbon source [Tanaka et al., 
1967]. The media was supplemented with NH 4 H 2 PO 4 , NaNO 3 and 
a variety of purines as nitrogen sources. Agar plates were prepared 
by the addition of 1.6% (w/v) agar to the liquid media.
 Dry cell weight (dcw) was determined by recovering cells from 
1-ml samples of culture, washing twice in distilled water and dry-
ing until no further change in weight occurred.
 Isolation of the AGDA Gene and Construction of Agdap 
Expression Plasmids in E. coli 
 The  AGDA gene was identified by screening the entire  A. ade-
ninivorans LS3 genome for sequences that correspond to known 
 AGDA  gene sequences. The  A. adeninivorans LS3  AGDA nucleo-
tide sequence has been submitted to the GenBank/EMBL data li-
braries (HG315954).
 To express a recombinant Agda protein (Agdap) in  A. 
 adeninivorans G1212, the  AGDA ORF was amplified by PCR using 
chromosomal DNA of  A. adeninivorans LS3 as template and prim-
ers ( table 7 ) with the gene sequence flanked by  Eco RI (AGDA5) 
and  Not I (AGDA3) restriction sites with the primer with coding 
sequence for 6 histidines at the 3 ′ -end of the ORF (AGDA3-His) 
used to create the HisTag proteins. The amplified  Eco RI- AGDA -
 Not I and  Eco RI- AGDA6H - Not I gene fragments, which corre-
spond to the complete ORF, were inserted into the plasmid pBS-
TEF1-PHO5-SS [Böer et al., 2005; Steinborn et al., 2006] between 
the  A. adeninivorans -derived constitutive  TEF1 promoter and the 
 S. cerevisiae -derived  PHO5 terminator [Arima et al., 1983; Rösel 
and Kunze, 1995].
 The promoter-gene-terminator sequences, flanked by  Spe I and 
 Sac II restriction sites, were inserted into the plasmid Xplor2.2 
[Böer et al., 2009b] to generate the plasmids, Xplor2.2-TEF1- 
AGDA and Xplor2.2-TEF1-AGDA6H. In the Xplor2.2 plasmid, 
the selection marker module ( ALEU2  promoter- ATRP1m ) and 
 Eco 47III,  Spe I,  Sac II,  Sal I,  Apa I multicloning restriction sites for 
insertion are flanked by 25S rDNA target sequences.
 The plasmids, constructed in  E. coli, were digested with  Asc I 
and  Sbf I to remove  E. coli sequences and the resulting linear cas-
settes ( fig. 2 ) were then introduced into  A. adeninivorans G1212.
 Transformation Procedures, Isolation and Characterisation of 
Nucleic Acids 
 Transformation of  E. coli XL1-Blue competent cells from 
Stratagene followed the procedure described by Inoue et al. 
[1990].  A. adeninivorans G1212 cells were transformed according 
to Rösel and Kunze [1998]. After passage on selective and non-
selective media, stable yeast transformants were obtained 
[Klabunde et al., 2003]. Isolation of plasmid DNA was performed 
using buffers from Qiagen (Hilden, Germany). Restriction frag-
ments were produced by the method described in the instruction 
manual for ‘ NucleoSpin ® Extract II kit ’ (Macherey-Nagel, Düren, 
Germany).
 The isolation of total RNA was done with yeast cells suspended 
in lysis buffer (8  M guanidine hydrochloride, 20 m M MES, 20 m M 
EDTA, 1.25% (v/v) β-mercaptoethanol, pH 7.0) [Logemann et al., 
1987]. The DNA was completely digested with DNase I (Fermen-
tas GmbH, St. Leon-Rot, Germany) using the method described in 
thr manufacturer’s instructions. cDNA was synthesised following 
the methods provided in the instruction manual ‘ Revert Aid TM H 
Minus – First Strand cDNA Synthesis ’ (Fermentas GmbH).
 In order to quantify the  AGDA transcript accumulation by 
qRT-PCR, appropriate fragments were amplified by PCR using 
‘ POWER SYBR ® Green PCR ’ master mix (Applied Biosystems, 
Inc., Forest City, Calif., USA) in ‘ ABI PRISM 7700 Sequence Detec-
tion ’ system (Applied Biosystems, Inc.) using the primers listed in 
 table 7 . The relative expression level of  AGDA mRNA was calcu-
lated as described in Hellemans et al. [2007] with  Arxula genes 
 AHBS4 ,  ALG9 ,  TEF1 and  TFIID as stably expressed endogenous 
references.
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 Enzyme Assays and Protein Analyses 
 Cells were harvested, washed, suspended in 500 μl 0.1  M potas-
sium phosphate buffer pH 6.5 (PP-buffer) with 500 μl of silica 
beads (0.5 mm; BioSpec Products, Bartlesville, Okla.,USA) and 
shaken for 3 min at 30 Hz in Mixer Mill (MM 400; Retsch GmbH, 
Haan, Germany). The supernatant was separated from cell mate-
rial and silica beads by centrifuging at 11,000  g , 10 min, 4  °  C and 
used for analysis.
 Guanine deaminase activity was assayed by quantification of 
(A) guanine and (B) ammonia. For (A), the enzymatic activity was 
determined spectrophotometrically by monitoring the decrease in 
absorbance at 250 nm using the coefficient 9.0 × 10 3 l/(mol cm) 
[Kalckar, 1947]. Standard assay mixtures containing the sample, 
0.1  M PP-buffer pH 8.0 and 0.2 m M guanine were incubated at 
37   °   C. One unit of guanine deaminase activity was defined as the 
ability to catalyse the transformation of 1 μmol guanine to xan-
thine per minute at 37   °   C. The ammonia quantification (B) was 
performed by a modified of a procedure described by Caraway 
[1966]. The sample was heated to 55   °   C (10 min) in 0.4 ml 0.1  M 
PP-buffer pH 6.0 and the reaction initiated by adding 100 μl gua-
nine (1.3 m M ). The reaction was incubated for 20 min at 55  °  C and 
stopped with the addition of 0.1 ml 1.8% sulphuric acid. In the 
control, guanine was added after this step. Equal volumes of co-
lour reagent (4.4% (v/v) phenol, 0.025% (w/v) sodium nitroprus-
side) and alkaline solution (2.5% (w/v) NaOH, 0.21% (v/v) sodium 
hypochlorite) was added to the clear supernatant followed by in-
cubation for 15 min at 37  °  C. The assay was measured at 630 nm. 
One unit of guanine deaminase was defined as the amount of en-
zyme required to deaminate 1 μmol guanine per minute at 37  °  C.
 Glucose-6-phosphate dehydrogenase activity was measured 
according to Gibon et al. [2004] and the α-mannosidase assay was 
performed as described by Opheim [1978].
 Purified endogenous guanine deaminase was from  A. adenini-
vorans LS3 cells that were cultured for 24 h in YMM-glucose sup-
plemented with 43.5 m M NaNO 3 at 30   °   C, washed and shifted to 
YMM-glucose supplemented with 5 m M hypoxanthine as the ni-
trogen source for 6 h. Transformants were cultivated 24 h in 
YMM-glucose-NaNO 3 . Cells were harvested, suspended in 0.1  M 
PP-buffer pH 6.5 and disrupted using Mill MM 400 mixer (Retsch 
GmbH) with silica beads.
 The crude extract of guanine deaminase was incubated for 30 min 
at 60   °   C and precipitated proteins were separated by centrifugation 
(10,000  g , 15 min, 4  °  C). The clear supernatant was purified to homo-
geneity by DEAE-Sepharose column chromatography and gel filtra-
tion on Superdex TM 200 column [Böer et al., 2009a]. The calibration 
standards were dextran blue (M r 2,000 kDa), ferritin (M r 443 kDa), 
catalase (M r 232 kDa), alcohol dehydrogenase (M r 150 kDa), bovine 
serum albumin (BSA) (M r 67 kDa) and ovalbumin (M r 42.8 kDa).
 Recombinant guanine deaminase with HisTag (Agda6hp) was 
purified by column chromatography on His-Bind resin (Novagen, 
Inc., Madison, Wisc., USA) according to the manufacturer’s in-
structions.
 Endogenous and recombinant guanine deaminase were electro-
phoretically separated and analysed by SDS-PAGE under denatur-
Table 7. PCR and qRT-PCR primers used in the construction of the plasmids pBS-TEF1-AGDA-PHO5-SS and pBS-TEF1-AGDA6H-
PHO5-SS and in the calculation of  AGDA transcript accumulation in  A. adeninivorans LS3
Name Nucleotide sequence Feature
AGDA5 5′-ATTAGAATTCATGACTCGAAAGGCGTTTTGC-3′ EcoRI restriction site
AGDA3 5′-TAATGCGGCCGCTTAGTTTGAGGATCCATCTTTG-3′ NotI restriction site
AGDA3-His 5′-TAATGCGGCCGCTTAATGGTGATGGTGATGATGGTT 
TGAGGATCCATCTTTG-3′
NotI restriction site and coding 
sequence for 6 histidines
AGDA-fw-rtPCR 5′-GATGACCGTAACACTCGCA-3′ Amplification in qRT-PCR
AGDA-rv-rtPCR 5′-CGTACAGCAGAGGTCGAGA-3′ Amplification in qRT-PCR
AHSB4-fw-rtPCR 5′-CTCATTTATGAGGAGACCCG-3′ Amplification in qRT-PCR
AHSB4-rv-rtPCR 5′-ATAAAGAGTTCGTCCCTGTC-3′ Amplification in qRT-PCR
ALG9-fw-rtPCR 5′-CATGGGCCAAGGTATACTG-3′ Amplification in qRT-PCR
ALG9-rv-rtPCR 5′-AGAATGCGACCGATACCA-3′ Amplification in qRT-PCR
TEF1-fw-rtPCR 5′-CTCTTGGACGATTCGCC-3′ Amplification in qRT-PCR
TEF1-rv-rtPCR 5′-CCGTTACCGACAATCTATTT-3′ Amplification in qRT-PCR
TFIID-fw-rtPCR 5′-AGTTTGTGTCTGATATTGCCTC-3′ Amplification in qRT-PCR
TFIID-rv-rtPCR 5′-GAAGAGCTTGCTACCGAACT-3′ Amplification in qRT-PCR
 EcoRI (GAATTC) and NotI (GCGGCCGC) restriction sites are underlined; the sequences coding the 6 histidines are given in italic 
type; the sequence corresponding to the ORFs is given in bold type.
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ing conditions [Laemmli, 1970]. Proteins were blotted to polyvinyl-
idene difluoride membranes (Millipore Corp., Billerica, Mass., USA) 
according to Towbin et al. [1979] and treated with anti-HisTag-spe-
cific antibodies according the manufacturer’s instructions.
 The dye-binding method of Bradford [1976] was used for pro-
tein quantification using BSA as standard.
 Subcellular Fractionation 
 A. adeninivorans LS3 and transgenic  A. adeninivorans G1212 
strains were cultured in YMM-glucose supplemented with 2.5 m M 
adenine or 43.5 m M NaNO 3 as nitrogen sources respectively. The 
cells were inoculated at an OD 600 nm of about 0.1 and grown to 
OD 600 nm 1.2 and harvested by centrifugation (5,000  g , 5 min, 
22   °   C). They were then washed in 0.9% NaCl and incubated in 
10  ml VBM solution (10 m M Tris, pH 9.0, 5 m M EDTA, 1% 
β-mercaptoethanol) for 10 min at 22  °  C. The cells were then washed 
twice with 0.9% NaCl before incubation in 1  M sorbitol supple-
mented with 0.3% (w/v) lysing enzyme from  Trichoderma harzia-
num (Sigma-Aldrich Corp., St. Louis, Mo., USA) at 22   °   C until at 
least 75% of cells became protoplasts [Maráz and Šubík, 1981].
 The protoplast preparation was centrifuged (2,500  g , 5 min, 
4   °   C), washed twice in 1  M sorbitol and then suspended in 0.4 ml 
1.8  M sorbitol with 3.2 ml 10 m M Tris pH 7.5 [Bryant and Boyd, 
1995]. Cell debris was removed by centrifugation at 1,000  g (5 min, 
4   °   C), and the supernatant was loaded onto a 17.5–40% sucrose 
density gradient and separated by ultracentrifugation in a Beck-
man L7-65 (Beckman Instruments, Fullerton, Calif., USA) in 
SW40 Ti-Rotor for 100,000  g , 150 min, 4  °  C. 0.5-ml fractions were 
collected from along the length of the tube.
 Degradation of Purines in Food 
 One gram of beef stock or 200 mg rolled fillet of ham was 
crushed, dissolved in 1.5 or 0.3 ml 0.5  M NaOH and 18.5 or 
1.2 ml 0.1  M PP-buffer pH 3.0 and treated with an enzyme mix-
ture. The enzyme mixture contained guanine deaminase, urate 
oxidase [Trautwein-Schult et al., 2013], adenine deaminase 
[Jankowska et al., 2013a] and xanthine oxidoreductase [Jankows-
ka et al., 2013b]. The sample was incubated at 40  °  C in the pres-
ence of 3 mg/ml NAD + . The reaction was stopped by heating at 
100   °   C for 5 min. After centrifugation, 20-μl samples of super-
natant were loaded onto an HPLC system (Hitachi LaChrom 
Elite ® L-2130; Merck, Darmstadt, Germany) equipped with a 
TSKgel Amide-80 analytical column (250 × 4.6 mm; Tosoh, To-
kyo, Japan) and fractionated by isocratic elution in acetonitrile 
and 0.1% trifluoroacetic acid (85: 15 v/v) at a flow rate of 1.2 ml/
min over a period of 20 min at 22   °   C. Detection was at 260 nm 
and the purines were identified by comparison to the retention 
times of pure uric acid, guanine, xanthine, hypoxanthine and 
adenine.
 Acknowledgements 
 The authors are grateful to Dr. M. Giersberg and Dr. S. Worch 
for helpful discussions and to R. Franz for excellent technical as-
sistance. The research work was supported by grants from the AiF, 
Arbeitsgemeinschaft industrieller Forschungsvereinigungen, Co-
logne (Project No. KF2131601MD8). 
 References 
 Arima K, Oshima T, Kubota I, Nakamura N, 
Mizunaga T, Toh-e A: The nucleotide se-
quence of the yeast  PHO5 gene: a putative 
precursor of repressible acid phosphatase 
contains a signal peptide. Nucleic Acids Res 
1983; 11: 1657–1672. 
 Barankiewicz J, Paszkowski J: Purine metabolism 
in mesophyll protoplasts of tobacco  (Nicotiana 
tabacum) leaves. Biochem J 1980; 186: 343–350. 
 Berger SJ, Carter JG, Lowry OH: Distribution of 
guanine deaminase in mouse brain. J Neuro-
chem 1985; 44: 1736–1740. 
 Bergstrom JD, Bieber AL: Characterization of pu-
rified guanine aminohydrolase. Arch Bio-
chem Biophys 1979; 194: 107–116. 
 Böer E, Bode R, Mock H-P, Piontek M, Kunze G: 
Atan1p – an extracellular tannase from the di-
morphic yeast  Arxula adeninivorans : molecu-
lar cloning of the  ATAN1 gene and character-
ization of the recombinant enzyme. Yeast 
2009a;26: 323–337. 
 Böer E, Breuer FS, Weniger M, Denter S, Piontek 
M, Kunze G: Large-scale production of tan-
nase using the yeast  Arxula adeninivorans . 
Appl Microbiol Biotechnol 2011;  92:  105–
114. 
 Böer E, Mock H-P, Bode R, Gellissen G, Kunze G: 
An extracellular lipase from the dimorphic 
yeast  Arxula adeninivorans : molecular clon-
ing of the  ALIP1 gene and characterization of 
the purified recombinant enzyme. Yeast 2005; 
 22: 523–535. 
 Böer E, Piontek M, Kunze G: Xplor ® 2 – an opti-
mized transformation/expression system for 
recombinant protein production in the yeast 
 Arxula adeninivorans . Appl Microbiol Bio-
technol 2009b;84: 583–594. 
 Böer E, Schröter A, Bode R, Piontek M, Kunze G: 
Characterization and expression analysis of a 
gene cluster for nitrate assimilation from the 
yeast  Arxula adeninivorans . Yeast 2009c;26: 
 83–93. 
 Bradford MM: A rapid and sensitive method 
for the quantitation of microgram quantities 
of protein utilizing the principle of protein-
dye binding. Anal Biochem 1976; 72: 248–
254. 
 Bryant NJ, Boyd A: Localization of a protein A-
tagged Kex2 protein to the vacuole of  Saccha-
romyces cerevisiae allows rapid purification 
of vacuolar membranes. Yeast 1995; 11: 201–
210. 
 Burns CM, Wortmann RL: Gout therapeutics: 
new drugs for an old disease. Lancet 2011; 377: 
 165–177. 
 Caraway WT: Colorimetric determination of se-
rum guanase activity. Clin Chem 1966; 12: 
 187–193. 
 Eggebeen AT: Gout: an update. Am Fam Physi-
cian 2007; 76: 801–808. 
 Emmerson BT: The management of gout. N Engl 
J Med 1996; 334: 445–451. 
 Fernández JR, Byrne B, Firestein BL: Phylogenet-
ic analysis and molecular evolution of gua-
nine deaminases: from guanine to dendrites. 
J Mol Evol 2009; 68: 227–235. 
 Fernández JR, Sweet ES, Welsh WJ, Firestein BL: 
Identification of small molecule compounds 
with higher binding affinity to guanine deam-
inase (cypin) than guanine. Bioorg Med 
Chem 2010; 18: 6748–6755. 
 Fogle PJ, Bieber AL: Purification of rabbit liver 
guanine aminohydrolase. Prep Biochem 1975; 
 5: 59–77. 
 Gibon Y, Blaesing OE, Hannemann J, Carillo P, 
Höhne M, Hendriks JHM, Palacios N, Cross J, 
Selbig J, Stitt M: A robot-based platform to 
measure multiple enzyme activities in  Arabi-
dopsis using a set of cycling assays: comparison 
of changes of enzyme activities and transcript 
levels during diurnal cycles and in prolonged 
darkness. Plant Cell 2004; 16: 3304–3325. 
 Gienow U, Kunze G, Schauer F, Bode R, Hofe-
meister J: The yeast genus  Trichosporon spec. 
LS3; molecular characterization of genomic 
complexity. Zentralbl Mikrobiol 1990; 145: 3–
12. 
 Trautwein-Schult   et al.  J Mol Microbiol Biotechnol 2014;24:67–81
DOI: 10.1159/000357674
80
 Giersberg M, Degelmann A, Bode R, Piontek M, 
Kunze G: Production of a thermostable alco-
hol dehydrogenase from  Rhodococcus ruber in 
three different yeast species using the Xplor ® 2 
transformation/expression platform. J Ind 
Microbiol Biotechnol 2012; 39: 1385–1396. 
 Glantz MD, Lewis AS: Guanine deaminase from 
rabbit liver. Methods Enzymol 1978; 72: 512–
517. 
 Groff GD, Franck WA, Raddatz DA: Systemic ste-
roid therapy for acute gout: a clinical trial and 
review of the literature. Semin Arthritis 
Rheum 1990; 19: 329–336. 
 Gupta NK, Glantz MD: Isolation and character-
ization of human liver guanine deaminase. 
Arch Biochem Biophys 1985; 236: 266–276. 
 Hayashi S, Fujiwara S, Noguchi T: Evolution of 
urate-degrading enzymes in animal peroxi-
somes. Cell Biochem Biophys 2000; 32: 123–
129. 
 Hellemans J, Mortier G, De Paepe A, Speleman F, 
Vandesompele J: qBase relative quantifica-
tion framework and software for manage-
ment and automated analysis of real-time 
quantitative PCR data. Genome Biol 2007; 
 8:RI9–RI9.14. 
 Hu M, Tomlinson B: Febuxostat in the manage-
ment of hyperuricemia and chronic gout: a 
review. Ther Clin Risk Manag 2008; 4: 1209–
1220. 
 Inoue H, Nojima H, Okayama H: High efficiency 
transformation of  Escherichia coli with plas-
mids. Gene 1990; 96: 23–28. 
 Ito S, Iwasaki A, Syundo J, Tamura Y, Kishi S, 
Mori H, Ii K, Matsuda Y, Katsunuma N: Char-
acterization of antibody against human liver 
guanase by immunoblotting and immunohis-
tochemical staining of human liver guanase by 
a direct labeling antibody-enzyme method. J 
Histochem Cytochem 1989; 37: 611–615. 
 Jankowska DA, Faulwasser K, Trautwein-Schult 
A, Cordes A, Hoferichter P, Klein C, Bode R, 
Baronian K, Kunze G:  Arxula adeninivorans 
recombinant adenine deaminase and its ap-
plication in the production of food with low 
purine content. J Appl Microbiol 2013a;115: 
 1134–1146.  
 Jankowska DA, Trautwein-Schult A, Cordes A, 
Hoferichter P, Klein C, Bode R, Baronian K, 
Kunze G:  Arxula adeninivorans xanthine oxi-
doreductase and its application in the produc-
tion of food with low purine content. J Appl 
Microbiol 2013b;115: 796–807. 
 Jordan KM: Up-to-date management of gout. 
Curr Opin Rheumatol 2012; 24: 145–151. 
 Kalckar HM: Differential spectrophotometry of 
purine compounds by means of specific en-
zymes: I. Determination of hydroxypurine 
compounds. J Biol Chem 1947; 167: 429–443. 
 Kaur P, Kunze G, Satyanarayana T: Yeast phy-
tases: present scenario and future perspec-
tives. Crit Rev Biotechnol 2007; 27: 93–109. 
 Keilin J: The biological significance of uric acid 
and guanine excretion. Biol Rev 1959; 34: 265–
296. 
 Kim G-J, Kim H-S: Identification of the structur-
al similarity in the functionally related amido-
hydrolases acting on the cyclic amide ring. 
Biochem J 1998; 330: 295–302. 
 Kim J, Park SI, Ahn C, Kim H, Yim J: Guanine 
deaminase functions as dihydropterin deami-
nase in the biosynthesis of aurodrosopterin, a 
minor red eye pigment of  Drosophila . J Biol 
Chem 2009; 284: 23426–23435. 
 Klabunde J, Kunze G, Gellissen G, Hollenberg 
CP: Integration of heterologous genes in sev-
eral yeast species using vectors containing a 
 Hansenula polymorpha -derived rDNA-tar-
geting element. FEMS Yeast Res 2003; 4: 185–
193. 
 Kubo K, Honda H, Sannomiya K, Aying Y, Mei 
W, Mi S, Aoyagi E, Simizu I, Ii K, Ito S: His-
tochemical and immunohistochemical inves-
tigation of guanase and nedasin in human tis-
sues. J Med Investig 2006; 53: 264–270. 
 Kumar KS, Sitaramayya A, Krishnan PS: Guanine 
deaminase in rat liver and mouse liver and 
brain. Biochem J 1972; 128: 1079–1088. 
 Kumar S, Rathi M: Purification of guanine deam-
inase inhibitor from human brain. Neuro-
chem Res 1980; 5: 547–550. 
 Kutzing MK, Firestein BL: Altered uric acid levels 
and disease states. J Pharmacol Exp Ther 
2008; 324: 1–7. 
 Laemmli UK: Cleavage of structural proteins dur-
ing the assembly of the head of bacteriophage 
T4. Nature 1970; 227: 680–685. 
 Lehninger AL: Biosynthesis of amino acids, nu-
cleotides, and related molecules; in Nelson 
DL, Cox MM (eds): Principles of Biochem-
istry. New York, Freeman, 2004, pp 833–
880. 
 Leinmüller R: Der Hyperurikämie mit Fasturtec 
begegnen. Dtsch Ärztebl 2001; 98:A3222. 
 Lewis AS, Glantz MD: Rabbit liver guanine de-
aminase. Chemical, physical, and kinetic 
properties. J Biol Chem 1974; 249: 3862–3866. 
 Liaw S-H, Chang Y-J, Lai C-T, Chang H-C, 
Chang G-G: Crystal structure of  Bacillus sub-
tilis guanine deaminase: the first domain-
swapped structure in the cytidine deaminase 
superfamily. J Biol Chem 2004; 279: 35479–
35485. 
 Logemann J, Schell J, Willmitzer L: Improved 
method for the isolation of RNA from plant 
tissues. Anal Biochem 1987; 163: 16–20. 
 Maráz A, Šubík J: Transmission and recombina-
tion of mitochondrial genes in  Saccharomyces 
cerevisiae after protoplast fusion. Mol Gen 
Genet 1981; 181: 131–133. 
 Maynes JT, Yuan RG, Snyder FF: Identification, 
expression, and characterization of  Escherich-
ia coli guanine deaminase. J Bacteriol 2000; 
 182: 4658–4680. 
 Middelhoven WJ, Hoogkamer-Te Niet MC, Kre-
ger-van Rij NJW:  Trichosporon adeninovo-
rans sp.  nov. , a yeast species utilizing adenine, 
xanthine, uric acid, putrescine and primary 
 n -alkylamines as the sole source of carbon, ni-
trogen and energy. Antonie van Leeuwen-
hoek 1984; 50: 369–378. 
 Miyamoto S, Ogawa H, Shiraki H, Nakagawa H: 
Guanine deaminase from rat brain. Purifica-
tion, characteristics, and contribution to am-
moniagenesis in the brain. J Biochem 1982; 91: 
 167–176. 
 Negishi O, Ozawa T, Imagawa H: Guanosine de-
aminase and guanine deaminase from tea 
leaves. Biosci Biotech Biochem 1994;  58: 
 1277–1281. 
 Nolan LL: Partial purification and characteriza-
tion of guanine aminohydrolase from  Try-
panosoma cruzi . Curr Microbiol 1984; 11: 
 217–220. 
 Nygaard P, Bested SM, Andersen KAK, Saxild 
HH:  Bacillus subtilis guanine deaminase is en-
coded by the  yknA gene and is induced during 
growth with purines as the nitrogen source. 
Microbiology 2000; 146: 3061–3069. 
 Opheim DJ: α- D -mannosidase of  Saccharomyces 
cerevisiae – characterization and modulation 
of activity. Biochim Biophys Acta 1978; 524: 
 121–130. 
 Pascual E, Sivera F, Yasothan U, Kirkpatrick P: 
Febuxostat. Nat Rev Drug Discov 2009; 8: 
 191–192. 
 Rösel H, Kunze G: Cloning and characterization 
of a  TEF gene for elongation factor 1α from 
the yeast  Arxula adeninivorans . Curr Genet 
1995; 28: 360–366. 
 Rösel H, Kunze G: Integrative transformation of 
the dimorphic yeast  Arxula adeninivorans 
LS3 based on hygromycin B resistance. Curr 
Genet 1998; 33: 157–163. 
 Rossi CA, Hakim G, Solaini G: Purification and 
properties of pig brain guanine deaminase. 
Biochim Biophys Acta 1978; 526: 235–246. 
 Roush AH, Questiaux LM, Domnas AJ: The active 
transport and metabolism of purines in the 
yeast,  Candida utilis . J Cell Comp Physiol 
1959; 54: 275–286. 
 Saag KG, Choi H: Epidemiology, risk factors, and 
lifestyle modifications for gout. Arthritis Res 
Ther 2006; 8(suppl 1):1–7. 
 Saint-Marc C, Daignan-Fornier B:  GUD1 
( YDL238c ) encodes  Saccharomyces cerevisiae 
guanine deaminase, an enzyme expressed 
during post-diauxic growth. Yeast 2004; 21: 
 1359–1363. 
 Schlesinger N, Yasothan U, Kirkpatrick P: Peglot-
icase. Nat Rev Drug Discov 2011; 10: 17–18. 
 Schmidt G: Über den fermentativen Abbau der 
Guanylsäure in der Kaninchenleber. Hoppe 
Seylers Z Physiol Chem 1932; 208: 185–224. 
 Sharma G, Verma I: Rasburicase. Indian J Phar-
macol 2004; 36: 109. 
 Shavlovskii GM, Kuznetsova RA: Influence of 
guanine on the growth, variability, and purine 
biosynthesis de novo in mutants of  Pichia 
guilliermondii with blocked guanine deami-
nase. Microbiol Rev 1974; 43: 858–863. 
 Snyder FF, Yuan RG, Bin JC, Carter KL, McKay 
DJ: Human guanine deaminase: cloning, ex-
pression and characterisation; in Zoref Shani 
E, Sperling O (eds): Purine and Pyrimidine 
Metabolism in Man X. Adv Exp Med Biol. 
New York, Kluwer Academic/Plenum, 2000, 
vol 486, pp 111–114. 
 Sorbera LA, Sharanya S, Dulsat C, Rosa E: Thera-
peutic targets for gout. Drug Future 2010; 35: 
 333–337. 
 Arxula adeninivorans Guanine Deaminase 
and Its Application 
 J Mol Microbiol Biotechnol 2014;24:67–81
DOI: 10.1159/000357674
81
 Steinborn G, Böer E, Scholz A, Tag K, Kunze G, 
Gellissen G: Application of a wide-range yeast 
vector (CoMed TM ) system to recombinant 
protein production in dimorphic  Arxula ad-
eninivorans , methylotrophic  Hansenula poly-
morpha and other yeasts. Microb Cell Fact 
2006; 5: 33–45. 
 Steinborn G, Gellissen G, Kunze G: A novel vector 
element providing multicopy vector integra-
tion in  Arxula adeninivorans . FEMS Yeast Res 
2007a;7: 1197–1205. 
 Steinborn G, Wartmann T, Gellissen G, Kunze G: 
Construction of an  Arxula adeninivorans 
host-vector system based on  trp1 comple-
mentation. J Biotechnol 2007b;127:  392–
401. 
 Sundy JS, Ganson NJ, Kelly SJ, Scarlett EL, Rehrig 
CD, Huang W, Hershfield MS: Pharmacoki-
netics and pharmacodynamics of intravenous 
PEGylated recombinant mammalian urate 
oxidase in patients with refractory gout. Ar-
thritis Rheum 2007; 56: 1021–1028. 
 Tanaka A, Ohishi N, Fukui S: Studies on the forma-
tion of vitamins and their functions in hydro-
carbon fermentation. IV. Production of vita-
min B 6 by  Candida albicans in a hydrocarbon 
medium. J Ferment Technol 1967; 45: 617–
632. 
 Tausche A-K, Jansen TL, Schröder H-E, Born-
stein SR, Aringer M, Müller-Ladner U: Gout – 
current diagnosis and treatment. Dtsch Ärz-
tebl Int 2009; 106: 549–555. 
 Terkeltaub RA: Update on gout: new therapeutic 
strategies and options. Nat Rev Rheumatol 
2010; 6: 30–38. 
 Terkeltaub RA, Furst DE, Bennett K, Kook KA, 
Crockett RS, Davis MW: High versus low dos-
ing of oral colchicine for early acute gout flare: 
twenty-four-hour outcome of the first multi-
center, randomized, double-blind, placebo-
controlled, parallel-group, dose-comparison 
colchicine study. Arthritis Rheum 2010; 62: 
 1060–1068. 
 Towbin H, Staehelin T, Gordon J: Electrophoret-
ic transfer of proteins from polyacrylamide 
gels to nitrocellulose sheets: procedure and 
some applications. Proc Natl Acad Sci USA 
1979; 76: 4350–4354. 
 Trautwein-Schult A, Jankowska D, Cordes A, 
Hoferichter P, Klein C, Matros A, Mock H-P, 
Baronian K, Bode R, Kunze G:  Arxula adenin-
ivorans recombinant urate oxidase and its ap-
plication in the production of food with low 
uric acid content. J Mol Microbiol Biotechnol 
2013; 23: 418–430. 
 Van der Walt JP, Smith MT, Yamada Y:  Arxula 
gen. nov. ( Candidaceae ), a new anamorphic, 
arthroconidial yeast genus. Antonie van 
Leeuwenhoek 1990; 57: 59–61. 
 Votchitseva YA, Efremenko EN, Aliev TK, Var-
folomeyev SD: Properties of hexahistidine-
tagged organophosphate hydrolase. Bichem 
(Mosc) 2006; 71: 167–172. 
 Wartmann T, Krüger A, Adler K, Duc BM, Kunze 
I, Kunze G: Temperature-dependent dimor-
phism of the yeast  Arxula adeninivorans LS3. 
Antonie van Leeuwenhoek 1995; 68: 215–223. 
 Wittköpper K, Emons J, El-Armouche A: Febuxo-
stat. Dtsch Med Wochenschr 2011; 136: 1270–
1274. 
 Wolfram G: Das moderne Konzept der Ernährung 
bei Gicht. Akt Ernähr-Med 1992; 17: 24–32. 
 Wolfram G, Colling M: Gesamtpuringehalt in 
ausgewählten Lebensmitteln. Z Ernährungs-
wiss 1987; 26: 205–213. 
 Yang X-X, Wartmann T, Stoltenburg R, Kunze G: 
Halotolerance of the yeast  Arxula adeniniv-
orans LS3. Antonie van Leeuwenhoek 2000; 
 77: 303–311. 
